Spider venom peptides as potential drug candidates due to their anticancer and antinociceptive activities
AUTOR(ES)
Wu, Ting
FONTE
J. Venom. Anim. Toxins incl. Trop. Dis
DATA DE PUBLICAÇÃO
03/06/2019
RESUMO
Abstract Spider venoms are known to contain proteins and polypeptides that perform various functions including antimicrobial, neurotoxic, analgesic, cytotoxic, necrotic, and hemagglutinic activities. Currently, several classes of natural molecules from spider venoms are potential sources of chemotherapeutics against tumor cells. Some of the spider peptide toxins produce lethal effects on tumor cells by regulating the cell cycle, activating caspase pathway or inactivating mitochondria. Some of them also target the various types of ion channels (including voltage-gated calcium channels, voltage-gated sodium channels, and acid-sensing ion channels) among other pain-related targets. Herein we review the structure and pharmacology of spider-venom peptides that are being used as leads for the development of therapeutics against the pathophysiological conditions including cancer and pain.
Documentos Relacionados
- Karyotypic “state” as a potential determinant for anticancer drug discovery
- Insects as biological models to assay spider and scorpion venom toxicity
- Centrosome cycle studies reveal promising candidates for anti-cancer drug design
- Characterization of Auxotrophic Mutants of Mycobacterium tuberculosis and Their Potential as Vaccine Candidates
- Synthesis of stimuli-sensitive copolymers by RAFT polymerization: potential candidates as drug delivery systems